He K, Berz D, Gadgeel SM, Iams WT, et al. MRTX-500 Phase 2 Trial: Sitravatinib With Nivolumab in Patients With Non-Squamous Non-Small Cell Lung Cancer Progressing On/After Checkpoint Inhibitor Therapy or Chemotherapy. J Thorac Oncol 2023 Feb 24:S1556-0864(23)00158.
PMID: 36842467